CorMedix (CRMD) Tops Q2 EPS by 2c

CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• Hagerty prices upsized secondary offering at $11.95 per share